HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Recurrent kidney stone — Clinical Guidelines

Overview

Recurrent kidney stones are a significant clinical challenge, with over 50% of patients experiencing recurrence within 5 years 2. Urolithiasis involves the formation of solid mineral deposits in the renal calyces and kidney pelvis, driven by mechanisms such as supersaturation, crystallization, and aggregation 3.

Diagnosis

Residual stone fragments (RSFs) are a determining factor in evaluating intervention outcomes, but definitions regarding size, location, and diagnosis lack consensus 1.

Most studies define RSFs as fragments < 4 mm, though thresholds vary 1.

For residual disease, patients with fragments ≤ 4 mm may be offered surveillance for up to 4 years, with intervention rates ranging from 17% to 29% 5.

Patients with larger residual fragments should be offered further definitive intervention due to high intervention rates (24-100%) 5.

Management

For patients with calcium oxalate urolithiasis who have undergone stone removal, a lime-based phytochemical-rich regimen (LPR) may prevent recurrence and reduce urinary inflammation over 24 months 2.

Hydrochlorothiazide is widely used for preventing calcium-containing kidney stone recurrence, though dose-response data are limited 6.

For patients with residual fragments ≤ 4 mm, surveillance for up to 4 years is an option, with spontaneous passage rates between 21% and 34% 5.

For patients with residual fragments > 4 mm, further intervention is recommended 5.

Phytochemicals such as Rubicodifolin, L-ascorbic acid, and Thymoquinone show promising activity in managing kidney stones 3.

For patients with radiopaque stones, imaging follow-up for at least 2 years is recommended before discharge; for radiolucent stones, 3 years is recommended 5. Patients should be discharged after 5 years of no recurrence with a 90% safety margin 5.

Special Populations

Recent evidence suggests the gender disparity in kidney stone disease is closing, with a greater rise in prevalence among females, especially adolescents 8. Females are also more likely to develop sepsis after endourological surgery 8.

Males are more likely to present with stone events during periods of high ambient temperatures 8.

The optimal frequency for shock wave lithotripsy (SWL) in pediatric renal stones is under investigation, with some evidence suggesting lower frequencies may be more advantageous, though requiring longer anesthesia times 10.

Key Recommendations

For patients with residual stone fragments ≤ 4 mm, surveillance for up to 4 years is a management option, with spontaneous passage rates between 21% and 34% 5. (Evidence: Moderate)

For patients with residual stone fragments > 4 mm, further definitive intervention should be offered 5. (Evidence: Moderate)

For patients with calcium oxalate urolithiasis who have undergone stone removal, a lime-based phytochemical-rich regimen may be considered to prevent recurrence over 24 months 2. (Evidence: Strong)

For patients with radiopaque stones, imaging follow-up for at least 2 years is recommended before discharge; for radiolucent stones, 3 years is recommended 5. (Evidence: Moderate)

References

1 Çavdar OF, Aydin A, Tokas T, Tozsin A, Gadzhiev N, Sönmez MG et al.. Residual stone fragments: systematic review of definitions, diagnostic standards. World journal of urology 2025. link 2 Dissayabutra T, Anegkamol W, Ratchanon S, Ungjaroenwathana W, Klinhom T, Sasivongsbhakdi T et al.. Lime-based supplement reduces calcium oxalate stone recurrence: A multicenter randomized controlled trial. PloS one 2025. link 3 Sharma K, Nagpal R, Pandey L, Mittal M, Sharma A, Lal Yadav R et al.. Recent Progression and Treatment Approaches for the Kidney Stone Management. Current drug targets 2025. link 4 Hosier GW, Beiko DT, Yang H, Sui W, Bayne D, Stoller ML et al.. A Multicenter Randomized Controlled Trial of Ambulatory Versus Inpatient Percutaneous Nephrolithotomy. European urology focus 2025. link 5 Tzelves L, Geraghty R, Lombardo R, Davis NF, Petřík A, Neisius A et al.. Duration of Follow-up and Timing of Discharge from Imaging Follow-up, in Adult Patients with Urolithiasis After Surgical or Medical Intervention: A Systematic Review and Meta-analysis from the European Association of Urology Guideline Panel on Urolithiasis. European urology focus 2023. link 6 Dhayat NA, Bonny O, Roth B, Christe A, Ritter A, Mohebbi N et al.. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. The New England journal of medicine 2023. link 7 Sorensen MD, Harper JD, Borofsky MS, Hameed TA, Smoot KJ, Burke BH et al.. Removal of Small, Asymptomatic Kidney Stones and Incidence of Relapse. The New England journal of medicine 2022. link 8 Gillams K, Juliebø-Jones P, Juliebø SØ, Somani BK. Gender Differences in Kidney Stone Disease (KSD): Findings from a Systematic Review. Current urology reports 2021. link 9 Hameed BMZ, Shah M, Naik N, Rai BP, Karimi H, Rice P et al.. The Ascent of Artificial Intelligence in Endourology: a Systematic Review Over the Last 2 Decades. Current urology reports 2021. link 10 Tuncer M, Kafkaslı A, Can U, Çoşkun A, Eryıldırım B, Sarica K. What is the optimal frequency in shock wave lithotripsy for pediatric renal stones? A prospective randomized study. Urolithiasis 2021. link 11 Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P et al.. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 2015. link

Recurrent kidney stone